Location History:
- Koriyama, JA (1976)
- Koriyama, JP (1980 - 1998)
Company Filing History:
27 out of 266 
3 out of 33 
1 out of 1 Years Active: 1976-1998
Title: Katsumasa Kuroiwa: Pioneering Innovations in Biomedicine
Introduction
Katsumasa Kuroiwa, a distinguished inventor based in Koriyama, Japan, has made significant contributions to the field of biomedicine, with a remarkable portfolio of 28 patents. His innovative work focuses on the development of therapeutic agents and diagnostic tools that address critical health issues.
Latest Patents
Among his most recent patents are two groundbreaking inventions. The first patent centers on a monoclonal antibody to prostate-derived acid phosphatase and method for its determination. This invention allows for the detection of prostate-derived acid phosphatase with exceptional sensitivity, utilizing hybridoma technology to create antibodies that are highly specific for the target enzyme.
The second notable patent involves novel tripeptide derivatives containing a pyroglutamic acid residue. These compounds have been shown to inhibit several trypsin-like serine proteases effectively, including plasmin, thrombin, and urokinase. Such innovative derivatives hold promise as novel protease inhibitors in the treatment of pancreatitis, inflammation, and ulcers.
Career Highlights
Throughout his career, Katsumasa Kuroiwa has held significant positions in reputable companies, contributing to their research and development efforts. Notably, he has worked for Nitto Boseki Co., Ltd. and Iatron Laboratories Inc., where he advanced his expertise in biomedical innovations and collaborations.
Collaborations
Katsumasa has collaborated with esteemed colleagues, including Takeshi Nagasawa and Yoshio Nakamura. Their combined efforts have been pivotal in the successful development of innovative solutions in the biomedical field, fostering advancements that benefit many.
Conclusion
Katsumasa Kuroiwa's fervent dedication to innovation in biomedicine is evident through his extensive patent portfolio and impactful collaborations. His work continues to hold significant potential for advancements in medical diagnostics and therapeutics, paving the way for future discoveries that can enhance patient care and treatment options.